Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 10-Feb-2018



Rhinostasis is an effective, easy-to-use, chemically treated nasal insert that will help stop nosebleeds. The insert could be used by healthcare professionals or be available to purchase over the counter. The blood-clotting chemical could also be applied to virtually any type of bandage, which would allow Rhinostasis to significantly expand its product line.

Additional Questions

Who is your customer?

The demographics most susceptible are children under age 10 and adults over 55. The most common cause of nosebleeds, particularly for children, is digital trauma to the anterior sinus, commonly referred to as nose picking. For the older demographic, a significant risk factor for difficult-to-control nosebleeds is blood thinners used for patients with atrial fibrillation and clots that form in lungs and legs, known as pulmonary emboli and deep-vein thromboses. Six percent of adults aged 60 and over are on blood thinners, and that jumps to 10 percent of adults over age 70 who are on blood thinners. Patients with blood-clotting disorders such as hemophilia are also susceptible to difficult-to-control nosebleeds.

What problem does this idea/product solve or what market need does it serve?

A nosebleed is not just an inconvenience. Currently one in every 200 emergency room visits is for a nosebleed, with an estimated 7 million cases annually. That means Americans are spending $8 billion every year for emergency room visits to treat nosebleeds.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

Dry inserts could be much more effective when impregnated with an antifibrinolytic and a vasoconstrictor to help clot blood and close vessels. These ideas came from my experience seeing doctors treat nosebleeds in emergency rooms. The compounds, which are inexpensive, are the topic of current research in treating bleeding. Many doctors are now starting to implement these chemicals and medicines into their practice. We would be making a product that combines the most cost-effective products into a convenient device that could be used by medical professionals or people at home.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

We have three partners on our team. We have a biochemistry major, a biology major, and an economics major with an emphasis in entrepreneurship. We have structured ourselves this way so we can synergize our unique abilities to create a scientifically proven and market-driven product. We also have many knowledgeable mentors in the colleges of science, health science, and business at Weber State who have been invaluable in developing and testing our product and business model. We have proven our potential already having one the Opportunity Quest at Weber State University that is a university-wide entrepreneurship contest hosted by the Hall Global Entrepreneurship Center.